Comparison of clinical outcomes of Chinese men and women after coronary stenting for coronary artery disease: A multi-center retrospective analysis of 4,334 patients

Journal of Biomedical Research

Volumn 28, Issue 5, 2014, Pages 368-375

  Shrestha, Rajiv ^a   Xu, Jing ^b   Xie, Dujiang ^b   Liu, Zhizhong ^b   Xu, Tian ^a   Ye, Fei ^b   Din, Shiqing ^c   Qian, Xuesong ^d   Yang, Song ^e   Liu, Yueqiang ^f   Li, Feng ^g   Zhang, Aiping ^h   Chen, Shaoliang ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c Huainan Xinhua Hospital   (China)

^d Zhangjiagang People's Hospital   (China)

^e Yixin People's Hospital   (China)

^f Jintan People's Hospital   (China)

^g Huainan Oriental General Hospital   (China)

^h Department of Cardiology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ACUTE HEART INFARCTION; ADULT; ANGIOGRAPHY; ARTICLE; CHINESE; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SEX DIFFERENCE; SILENT MYOCARDIAL ISCHEMIA; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; STENT THROMBOSIS; SURVIVAL; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 84936945076     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.28.20120127     Document Type: Article

References (26)

1. Song ZY, Zhang ZY, Xu ZS. Brief history of percutaneous coronary intervention. Zhonghua Yi Shi Za Zhi (in Chinese) 2010; 40: 180-3.
2. Yeh RW, Chandra M, McCulloch CE, Go AS. Accounting for the mortality benefit of drugeluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study. BMC Med 2011; 9: 78.
3. Yang PC, Clancy CE. Gender-based differences in cardiac diseases. Biomed Res 2011; 25: 81-9.
4. Ma J, Yang W, Singh M, Peng T, Fang N, Wei M. Meta-analysis of long-term outcomes of drug-eluting stent implantations for chronic total coronary occlusions. Heart Lung. 2011; 40: 32-40.
5. Liu Y, Wang LF, Yang XF, Ge YG, Xu L, Li WM, et al. Gender differences in efficacy of primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. Chin Med J 2008; 121: 2374-8.
6. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infraction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the management of patients with Unstable angina). J Am Coll Cardiol 2002;40: 1366-74.
7. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patient with ST-elevation myocardial infarction; a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infraction). J Am Coll Cardiol 2004; 44: E1-E211.
8. Laura M, Wen-hua H, Joseph MM, Kalon KL, Ralph DA, Donald EC. Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents. N Engl J Med 2007; 356:1020-9.
9. Berger JS, Elliott L, Gallup D, Roe M, Granger CB, Armstrong PW, et al. Sex differences in mortality following acute coronary syndromes. JAMA 2009; 302: 874-82.
10. Elizabeth AJ, Mauro M, Dean ES, David S, Simon D, Adam G, et al. The association of sex with outcomes among patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction in the contemporary era: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Am Heart J 2011; 161: 106-12.
11. Chen Z, Qian J, Ma J, Ge L, Ge J. Effect of gender on repeated coronary artery revascularization after intra-coronary stenting: a meta-analysis. Int J Cardiol 2012 14;157: 381-5.
12. Sabate M, Jimenez-Quevedo P, Angiolillo DJ, Gomez-Hospital JA, Alfonso F, Hernandez-Antolin R, et al. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 2005; 112: 2175-83.
13. Niles NW, McGrath PD, Malenka D, Quinton H, Wennberg D, Shubrooks SJ, et al. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 2001; 37: 1008-15.
14. Lincoff AM. Important triad in cardiovascular medicine: diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa receptor blockade. Circulation 2008; 107: 1556-9.
15. Mehilli J, Kastrati A, Bollwein H, Dibra A, Schuhlen H, Dirschinger J, et al. Gender and restenosis after coronary artery stenting. Eur Heart J 2003; 24: 1523-30.
16. Mehilli J, Kastrati A, Dirschinger J, Bollwein H, Neumann FJ, Schomig A. Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting. J Am Med Assoc 2000; 284:1799-805.
17. Ogita M, Miyauchi K, Dohi T, Wada H, Tuboi S, Miyazaki T, et al. Gender-based outcomes among patients with diabetes mellitus after percutaneous coronary intervention in the drug-eluting stent era. Int Heart J 2011;52: 348-52.
18. Spinler SA, Mahaffey KW, Gallup D, Levine GN, Ferguson JJ III, Rao SV, et al. Relationship between renal function and outcomes in high-risk patients with non-STsegment elevation acute coronary syndromes: Results from SYNERGY. Int J Cardiol 2010; 144: 36-41.
19. Lansky AJ, Hochman JS, Ward PA, Mintz GS, Fabunmi R, Berger PB, et al. Percutaneous coronary intervention and adjunctive pharmacotherapy in women. A statement for Healthcare Professionals from the American Heart Association. Circulation 2005; 111: 940-53.
20. Lee KH, Jeong MH, Ahn YK, Kim JH, Chae SC, Kim YJ, et al. Gender differences of success rate of percutaneous coronary intervention and short term cardiac events in Korea Acute Myocardial Infarction Registry. Int J Cardiol 2008; 130: 227-34.
21. Welty FK, Mittleman MA, Healy RW, Muller JE, Shubrooks SJ. Similar results of percutaneous transluminal coronary angioplasty for women and men with post myocardial infarction ischemia. J Am Coll Cardiol 1994, 23: 35-9.
22. Schuhlen H, Kastrati A, Dirschinger J, Hausleiter J, Elezi S, Wehinger A, et al. Intracoronary stenting and risk for major adverse cardiac events during the first month. Circulation 1998, 98: 104-11.
23. Zhang QY, Li Y, Guan SY, Wang XZ, Jing QM, Ma YY, et al. Incidence and predictors of definite stent thrombosis after coronary stent implantation. Chin Med J (Engl) 2012;125: 1547-51.
24. Brener SJ, Steinhubl SR, Berger PB, Brennan DM, Topol EJ, CREDO Investigators. Prolonged dual antiplatelet therapy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization: insights from the CREDO trial. J Invasive Cardiol 2007; 19: 287-90.
25. Harmsze AM, van Werkum JW, Ten Berg JM, Zwart B, Bouman HJ, Breet NJ, et al. CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study. Eur Heart J 2010; 31: 3046-53.
26. Nguyen JT, Berger AK, Duval S, Luepker RV. Gender disparity in cardiac procedures and medication use for acute myocardial infarction. Am Heart J 2008; 155:862-68.